» Articles » PMID: 21221816

Estimation of the Impact of Diabetes-related Complications on Health Utilities for Patients with Type 2 Diabetes in Ontario, Canada

Overview
Journal Qual Life Res
Date 2011 Jan 12
PMID 21221816
Citations 31
Authors
Affiliations
Soon will be listed here.
Abstract

Objectives: The goal of this study was to analyze health-related quality of life (HRQL) data from a Canadian population with type 2 diabetes in order to estimate the disutility associated with experiencing a diabetes-related complication.

Methods: The EQ-5D, a standardized instrument for use as a measure of health outcome, was administered to 1,147 patients in Hamilton, Ontario, with type 2 diabetes. After controlling for age, gender, and duration of diabetes, changes in utility values were estimated by regressing the EQ-5D scores onto binary indicators for the presence of an event. The primary method of analysis was Ordinary Least Squares (OLS) and due to concerns over non-Normality, bootstrap standard errors (SE) were calculated.

Results: The analysis included 1,143 participants. Based on the OLS model, reductions in HRQL were associated with duration of diabetes (-0.0015, SE = 0.0006), experiencing a myocardial infarction (MI) (-0.059, SE = 0.017), amputation (-0.063, SE = 0.059), stroke (-0.046, SE = 0.023), and kidney failure (-0.102, SE = 0.047).

Conclusion: This study estimated the reductions in HRQL associated with several important complications commonly experienced in patients with diabetes. The greatest impacts on HRQL were associated with kidney failure and MI. The utility values calculated here can be used to assess the outcome of interventions that reduce these diabetes-related complications and will have a useful impact on future economic evaluations of diabetes management strategies in Canada.

Citing Articles

Assessment of Health-Related Quality of Life Among Patients with Chronic Diseases and Its Relationship with Multimorbidity: A Cross-Sectional Study from Saudi Arabia.

Alzarea A, Khan Y, Alzarea S, Alanazi A, Alsaidan O, Alrowily M Patient Prefer Adherence. 2024; 18:1077-1094.

PMID: 38854480 PMC: 11162240. DOI: 10.2147/PPA.S448915.


Utilities for Complications Associated with Type 2 Diabetes: A Review of the Literature.

Valentine W, Norrbacka K, Boye K Adv Ther. 2024; 41(7):2655-2681.

PMID: 38771477 PMC: 11213775. DOI: 10.1007/s12325-024-02878-x.


Health state utility values ranges across varying stages and severity of type 2 diabetes-related complications: A systematic review.

Tan M, Ong S, Mohd Tahir N, Mhd Ali A, Mustafa N PLoS One. 2024; 19(4):e0297589.

PMID: 38574169 PMC: 10994347. DOI: 10.1371/journal.pone.0297589.


Bariatric Surgery for Adults With Class I Obesity and Difficult-to-Manage Type 2 Diabetes: A Health Technology Assessment.

Ont Health Technol Assess Ser. 2023; 23(8):1-151.

PMID: 38130940 PMC: 10732121.


Assessing health-related quality of life of people with diabetes in Nigeria using the EQ-5D-5L: a cross-sectional study.

Jackson I, Isah A, Arikpo A Sci Rep. 2023; 13(1):22536.

PMID: 38110447 PMC: 10728144. DOI: 10.1038/s41598-023-49322-8.


References
1.
Anderson R, Fitzgerald J, Wisdom K, Davis W, HISS R . A comparison of global versus disease-specific quality-of-life measures in patients with NIDDM. Diabetes Care. 1997; 20(3):299-305. DOI: 10.2337/diacare.20.3.299. View

2.
Wexler D, Grant R, Wittenberg E, Bosch J, Cagliero E, Delahanty L . Correlates of health-related quality of life in type 2 diabetes. Diabetologia. 2006; 49(7):1489-97. DOI: 10.1007/s00125-006-0249-9. View

3.
Rubin R, Peyrot M . Quality of life and diabetes. Diabetes Metab Res Rev. 1999; 15(3):205-18. DOI: 10.1002/(sici)1520-7560(199905/06)15:3<205::aid-dmrr29>3.0.co;2-o. View

4.
Maddigan S, Feeny D, Johnson J . A comparison of the health utilities indices Mark 2 and Mark 3 in type 2 diabetes. Med Decis Making. 2003; 23(6):489-501. DOI: 10.1177/0272989X03258438. View

5.
Glasziou P, Alexander J, Beller E, Clarke P . Which health-related quality of life score? A comparison of alternative utility measures in patients with Type 2 diabetes in the ADVANCE trial. Health Qual Life Outcomes. 2007; 5:21. PMC: 1950473. DOI: 10.1186/1477-7525-5-21. View